These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 3206151

  • 1. [Calcium antagonists in the treatment of Raynaud's syndrome and in the treatment of esophageal spasm].
    Kahan A, Amor B, Menkès CJ.
    Rev Prat; 1988 Nov 17; 38(27):1986-8. PubMed ID: 3206151
    [No Abstract] [Full Text] [Related]

  • 2. [Calcium antagonists and Raynaud's phenomenon].
    Hachulla E, Devulder B.
    Therapie; 1993 Nov 17; 48 Spec No():707-11. PubMed ID: 8091357
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of Raynaud's syndrome in systemic connective tissue diseases with calcium antagonists].
    Shcherbakov AB.
    Vutr Boles; 1988 Nov 17; 27(6):55-8. PubMed ID: 3247706
    [Abstract] [Full Text] [Related]

  • 4. [Calcium antagonists in Raynaud's disease].
    Gjørup T, Hartling OJ, Kelbaek H, Nielsen SL.
    Ugeskr Laeger; 1986 Nov 24; 148(48):3236-7. PubMed ID: 3544411
    [No Abstract] [Full Text] [Related]

  • 5. [Treatment of Raynaud's phenomenon].
    Lazareth I.
    Ann Dermatol Venereol; 1987 Nov 24; 114(8):1035-8. PubMed ID: 2892456
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of Raynaud's syndrome with calcium entry blockers].
    Shcherbakov AB, Guseva NG, Mach ES.
    Ter Arkh; 1987 Nov 24; 59(4):89-92. PubMed ID: 3296288
    [Abstract] [Full Text] [Related]

  • 7. [Raynaud's phenomenon; diagnosis and treatment].
    Hofstee HM, Voskuyl AE, Serné EH, Smulders YM.
    Ned Tijdschr Geneeskd; 2009 Nov 24; 153():B216. PubMed ID: 19785782
    [Abstract] [Full Text] [Related]

  • 8. Calcium blockers in smooth-muscle disorders. Current status.
    Schwartz ML, Rotmensch HH, Vlasses PH, Ferguson RK.
    Arch Intern Med; 1984 Jul 24; 144(7):1425-9. PubMed ID: 6375615
    [Abstract] [Full Text] [Related]

  • 9. Treatment for Raynaud's: beyond calcium channel blockers.
    Bergstrom KG, Perelman RO.
    J Drugs Dermatol; 2008 May 24; 7(5):497-500. PubMed ID: 18505148
    [No Abstract] [Full Text] [Related]

  • 10. [Management of Raynaud's phenomenon].
    Boccalon H, Monin A, Reggy M.
    Soins Cardiol; 1986 Apr 24; (38):27-9. PubMed ID: 3637023
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of Raynaud's phenomenon.
    García-Carrasco M, Jiménez-Hernández M, Escárcega RO, Mendoza-Pinto C, Pardo-Santos R, Levy R, Maldonado CG, Chávez GP, Cervera R.
    Autoimmun Rev; 2008 Oct 24; 8(1):62-8. PubMed ID: 18692160
    [Abstract] [Full Text] [Related]

  • 12. [How I treat...Raynaud's phenomenon].
    Piérard GE.
    Rev Med Liege; 1998 Mar 24; 53(3):119-20. PubMed ID: 9594609
    [Abstract] [Full Text] [Related]

  • 13. Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis.
    Thompson AE, Shea B, Welch V, Fenlon D, Pope JE.
    Arthritis Rheum; 2001 Aug 24; 44(8):1841-7. PubMed ID: 11508437
    [Abstract] [Full Text] [Related]

  • 14. Raynaud's phenomenon.
    O'connor CM.
    J Vasc Nurs; 2001 Sep 24; 19(3):87-92; quiz 93-4. PubMed ID: 11533581
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.